1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About

Alloy Therapeutics, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

Waltham MA US

Primary Industry

Biotechnology

About

Based in Massachusetts, US, and founded in 2017, Alloy Therapeutics, Inc. operates as a biotechnology ecosystem company. The company was founded by Errik Anderson. In April 2021, Alloy Therapeutics, Inc. raised its latest series C funding from 8VC and Presight Capital. Alloy Therapeutics, Inc. is a developer of ATX-Gx™ drug discovery platform that offers mice to their lab for immunizations. Alloy Therapeutics, Inc. plans to use its funding from April to advance platforms and resources used by scientific entrepreneurs to turn ideas into biological medicines.
Current Investors
Alexandria Venture Investments, Founders Fund, 8VC

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.alloytx.com
Company Stage
Series D
Total Amount Raised
Subscriber access only

Key Contacts

Name Position Start Date End Date Vcard Bio
Member, Scientific Advisory Board BM
Board Member BM
BM Board Member
Name Firm Deal Date Number Of Deals Vcard
AI LP
AI LP
AI Active Investor LP Lead Provider

Want to see more?

Request a demo for full access to this profile.

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.